Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–62.

Article  PubMed  PubMed Central  Google Scholar 

Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105–25.

Article  Google Scholar 

Koch G, Casula EP, Bonnì S, Borghi I, Assogna M, Minei M, et al. Precuneus magnetic stimulation for Alzheimer’s disease: a randomized, sham-controlled trial. Brain. 2022;145(11):3776–86.

Article  PubMed  PubMed Central  Google Scholar 

Jutten RJ, Papp KV, Hendrix S, Ellison N, Langbaum JB, Donohue MC, et al. Why a clinical trial is as good as its outcome measure: a framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer’s disease. Alzheimers Dement. 2023;19(2):708–20.

Article  PubMed  Google Scholar 

Schneider LS, Goldberg TE. Composite cognitive and functional measures for early stage Alzheimer’s disease trials. Alzheimers Dement. 2020;12(1):e12017.

Google Scholar 

Cummings J, Feldman HH, Scheltens P. The "rights" of precision drug development for Alzheimer's disease. Alzheimers Res Ther. 2019;11(1):76.

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, et al. Alzheimer’s disease. The Lancet. 2021;397(10284):1577–90.

Article  CAS  Google Scholar 

Babiloni C, Arakaki X, Azami H, Bennys K, Blinowska K, Bonanni L, et al. Measures of resting state EEG rhythms for clinical trials in Alzheimer’s disease: recommendations of an expert panel. Alzheimers Dementia. 2021;17(9):1528–53.

Article  Google Scholar 

van Straaten EC, Scheltens P, Gouw AA, Stam CJ. Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics. Alzheimers Res Ther. 2014;6(9):1–10.

Google Scholar 

Gouw AA, Alsema AM, Tijms BM, Borta A, Scheltens P, Stam CJ, et al. EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjects. Neurobiol Aging. 2017;57:133–42.

Article  PubMed  Google Scholar 

Musaeus CS, Engedal K, Høgh P, Jelic V, Mørup M, Naik M, et al. EEG theta power is an early marker of cognitive decline in dementia due to Alzheimer’s disease. J Alzheimers Dis. 2018;64(4):1359–71.

Article  PubMed  Google Scholar 

Babiloni C, Binetti G, Cassetta E, Cerboneschi D, Dal Forno G, Del Percio C, et al. Mapping distributed sources of cortical rhythms in mild Alzheimer’s disease. A multicentric EEG study. Neuroimage. 2004;22(1):57–67.

Article  PubMed  Google Scholar 

Huang C, Wahlund L, Dierks T, Julin P, Winblad B, Jelic V. Discrimination of Alzheimer’s disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study. Clin Neurophysiol. 2000;111(11):1961–7.

Article  CAS  PubMed  Google Scholar 

Jeong J. EEG dynamics in patients with Alzheimer’s disease. Clin Neurophysiol. 2004;115(7):1490–505.

Article  PubMed  Google Scholar 

Briels CT, Stam CJ, Scheltens P, Bruins S, Lues I, Gouw AA. In pursuit of a sensitive EEG functional connectivity outcome measure for clinical trials in Alzheimer’s disease. Clin Neurophysiol. 2020;131(1):88–95.

Article  CAS  PubMed  Google Scholar 

Stam C, De Haan W, Daffertshofer A, Jones B, Manshanden I, van Cappellen van Walsum A-M, et al. Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer’s disease. Brain. 2009;132(1):213–24.

Article  CAS  PubMed  Google Scholar 

Stam CJ, Jones B, Manshanden I, Van Walsum AvC, Montez T, Verbunt JP, et al. Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer’s disease. Neuroimage. 2006;32(3):1335–44.

Article  CAS  PubMed  Google Scholar 

Crossley NA, Mechelli A, Scott J, Carletti F, Fox PT, McGuire P, et al. The hubs of the human connectome are generally implicated in the anatomy of brain disorders. Brain. 2014;137(8):2382–95.

Article  PubMed  PubMed Central  Google Scholar 

De Haan W, Mott K, Van Straaten EC, Scheltens P, Stam CJ. Activity dependent degeneration explains hub vulnerability in Alzheimer’s disease. 2012.

Google Scholar 

Van den Heuvel MP, Sporns O. Network hubs in the human brain. Trends Cogn Sci. 2013;17(12):683–96.

Article  PubMed  Google Scholar 

Yu M, Engels MMA, Hillebrand A, van Straaten ECW, Gouw AA, Teunissen C, et al. Selective impairment of hippocampus and posterior hub areas in Alzheimer’s disease: an MEG-based multiplex network study. Brain. 2017;140(5):1466–85.

Article  PubMed  Google Scholar 

Ando M, Nobukawa S, Kikuchi M, Takahashi T. Identification of Electroencephalogram Signals in Alzheimer's Disease by Multifractal and Multiscale Entropy Analysis. Front Neurosci. 2021;15:667614.

Echegoyen I, López-Sanz D, Martínez JH, Maestú F, Buldú JM. Permutation entropy and statistical complexity in mild cognitive impairment and Alzheimer’s disease: an analysis based on frequency bands. Entropy. 2020;22(1):116.

Article  PubMed  PubMed Central  Google Scholar 

Maturana-Candelas A, Gómez C, Poza J, Pinto N, Hornero R. EEG characterization of the Alzheimer’s disease continuum by means of multiscale entropies. Entropy. 2019;21(6):544.

Article  PubMed  PubMed Central  Google Scholar 

Shumbayawonda E, López-Sanz D, Bruña R, Serrano N, Fernández A, Maestú F, et al. Complexity changes in preclinical Alzheimer’s disease: an MEG study of subjective cognitive decline and mild cognitive impairment. Clin Neurophysiol. 2020;131(2):437–45.

Article  PubMed  Google Scholar 

Kowalski JW, Gawel M, Pfeffer A, Barcikowska M. The diagnostic value of EEG in Alzheimer disease: correlation with the severity of mental impairment. J Clin Neurophysiol. 2001;18(6):570–5.

Article  CAS  PubMed  Google Scholar 

Briels CT, Stam CJ, Scheltens P, Gouw AA. The predictive value of normal EEGs in dementia due to Alzheimer’s disease. Ann Clin Transl Neurol. 2021;8(5):1038–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gianotti LR, Künig G, Lehmann D, Faber PL, Pascual-Marqui RD, Kochi K, et al. Correlation between disease severity and brain electric LORETA tomography in Alzheimer’s disease. Clin Neurophysiol. 2007;118(1):186–96.

Article  PubMed  Google Scholar 

Benwell CSY, Davila-Pérez P, Fried PJ, Jones RN, Travison TG, Santarnecchi E, et al. EEG spectral power abnormalities and their relationship with cognitive dysfunction in patients with Alzheimer’s disease and type 2 diabetes. Neurobiol Aging. 2020;85:83–95.

Article  PubMed  Google Scholar 

Fonseca LC, Tedrus GM, Prandi LR, Almeida AM, Furlanetto DS. Alzheimer’s disease: relationship between cognitive aspects and power and coherence EEG measures. Arq Neuropsiquiatr. 2011;69(6):875–81.

Article  PubMed  Google Scholar 

Yang AC, Wang SJ, Lai KL, Tsai CF, Yang CH, Hwang JP, et al. Cognitive and neuropsychiatric correlates of EEG dynamic complexity in patients with Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2013;47:52–61.

Article  PubMed  Google Scholar 

Rossini PM, Del Percio C, Pasqualetti P, Cassetta E, Binetti G, Dal Forno G, et al. Conversion from mild cognitive impairment to Alzheimer’s disease is predicted by sources and coherence of brain electroencephalography rhythms. Neuroscience. 2006;143(3):793–803.

Article  CAS  PubMed  Google Scholar 

Dattola S, La Foresta F. An eLORETA longitudinal analysis of resting state EEG rhythms in Alzheimer’s disease. Appl Sci. 2020;10(16):5666.

Article  CAS  Google Scholar 

Morabito FC, Campolo M, Labate D, Morabito G, Bonanno L, Bramanti A, et al. A longitudinal EEG study of Alzheimer’s disease progression based on a complex network approach. Int J Neural Syst. 2015;25(2):1550005.

Article  PubMed  Google Scholar 

Jelic V, Johansson S, Almkvist O, Shigeta M, Julin P, Nordberg A, et al. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer’s disease. Neurobiol Aging. 2000;21(4):533–40.

Article  CAS  PubMed  Google Scholar 

Lehtovirta M, Partanen J, Könönen M, Hiltunen J, Helisalmi S, Hartikainen P, et al. A longitudinal quantitative EEG study of Alzheimer’s disease: relation to apolipoprotein E polymorphism. Dement Geriatr Cogn Disord. 2000;11(1):29–35.

Article  CAS  PubMed  Google Scholar 

Meghdadi AH, Stevanović Karić M, McConnell M, Rupp G, Richard C, Hamilton J, et al. Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment. PLoS ONE. 2021;16(2):e0244180.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soininen H, Partanen J, Laulumaa V, Pääkkönen A, Helkala EL, Riekkinen PJ. Serial EEG in Alzheimer’s disease: 3 year follow-up and clinical outcome. Electroencephalogr Clin Neurophysiol. 1991;79(5):342–8.

Article  CAS  PubMed  Google Scholar 

Dubois B, Epelbaum S, Nyasse F, Bakardjian H, Gagliardi G, Uspenskaya O, et al. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer’s disease (INSIGHT-preAD): a longitudinal observational study. Lancet Neurol. 2018;17(4):335–46.

Article  CAS  PubMed  Google Scholar 

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia. 2011;7(3):263–9.

Article